stockrow
Friday 6 November 2026
Export CARL’s income statement to Excel — free account
Carlsmed, Inc.
CARL Healthcare Health Information Services
Carlsmed, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $50.5 million, up 85.9% from fiscal 2024.
- Revenue
- +56.8%
- EPS
- +73.5%
- Free cash flow
- −6.84%
- Total debt
- −0.32%
Quarter to June 2026, against a year earlier
14.42
0.90
−5.87%
Follow CARL
Alert me
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+5 more TTM periods Free account |
0.00% | (214.02%) | (301.61%) | (6,196.93%) | |
| (32.15%) | (46.45%) | (38.22%) | (42.39%) | ||
ROIC |
(273.81%) | (442.13%) | (203.24%) | (234.53%) | |
Return on Tangible Assets |
(24.65%) | (26.53%) | (30.39%) | (36.49%) | |
Average Days of Receivables |
98.32 | 82.10 | 79.34 | 79.44 | |
Free Cash Flow per Share |
(1.38) | (2.13) | (1.31) | (1.31) | |
Free Cash Flow |
(29.05) | (30.33) | (35.15) | (35.67) | |
Capital Expenditures |
(1.19) | (1.36) | (1.32) | (1.53) | |
| Other line items | |||||
Cash ROIC |
(12.23%) | (13.54%) | (17.17%) | (18.88%) | |
Accounts Receivable Turnover |
0.00 | 5.57 | 5.93 | 5.39 | |
Accounts Payable Turnover |
0.00 | 3.62 | 5.07 | 4.71 | |
Inventory Turnover |
0.00 | 8.78 | 8.90 | 8.85 | |
Average Days of Payables |
91.10 | 131.15 | 79.17 | 91.39 | |
Days of Inventory on Hand |
45.68 | 54.00 | 55.33 | 56.13 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
37.65% | 33.69% | 33.75% | 33.06% | |
Selling, General and Administrative Expense of Revenue |
106.05% | 102.15% | 102.61% | 104.65% | |
Share Based Compensation of Revenue |
2.87% | 3.82% | 5.99% | 8.52% | |
Interest Coverage |
(19.33) | (21.38) | (24.66) | (28.98) | |
Operating CF/Net income |
0.93 | 0.96 | 1.04 | 0.94 | |
Depreciation/Fixed assets |
0.19 | 0.19 | 0.21 | 0.17 | |
Capex/Depreciation |
(5.40) | (4.83) | (3.90) | (3.74) | |
Revenue per Share |
1.99 | 3.55 | 2.10 | 2.33 | |
Operating CF per Share |
(1.32) | (2.04) | (1.26) | (1.26) | |
Capex per Share |
(0.06) | (0.10) | (0.05) | (0.06) | |
Capex to Sales |
0.03 | 0.03 | 0.02 | 0.02 |
Columns are period end dates · fundamentals updated 26 Oct 2026